๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Special address: Safety of hepatitis B vaccination

โœ Scribed by Sieghart Dittmann

Book ID
117433738
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
69 KB
Volume
18
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Safety of hepatitis B vaccines
Safety of hepatitis B vaccines
โœ Arie J. Zuckerman ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 82 KB
Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
โœ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.

Protective efficacy, immunotherapeutic p
Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines
โœ Jane N. Zuckerman ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB

Hepatitis B vaccines are highly effective and safe and have been incorporated into national immunization programs in over 150 countries. The major humoral immune response is to the common a determinant of the surface antigen protein of the virus. Approximately 5-10% of healthy immunocompetent subjec